COMMUNIQUÉS West-GlobeNewswire

SAFE - Réalisation définitive de la réduction de capital non motivée par des pertes par voie de réduction de la valeur nominale des actions
16/10/2025
Réalisation définitive de la réduction de capital non motivée par des pertes par voie de réduction de la valeur nominale des actions Fleurieux-sur-l’Arbresle – France – 16 octobre 2025 - Safe (FR001400ZU25 – ALSAF) (la [...]
Enterome receives FDA Fast Track designation in follicular lymphoma for lead OncoMimics™ immunotherapy EO2463
16/10/2025
Covers low tumor burden “watch-and-wait” setting, an unmet medical need Registrational Phase 3 watch-and-wait to start in 2026 EO2463 has broad potential to treat hemato-oncology indications Paris, France – 16 OCTOBER, [...]
AdvanCell appoints experienced biotech and pharma leader, Andrew Kay, as Chair of the Board of Directors
16/10/2025
Kay was instrumental in driving the successful development and commercialization of Xofigo ® , the first and only approved alpha therapy to date SYDNEY, Australia - October 16, 2025 – AdvanCell, a clinical-stage [...]
The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira
16/10/2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COPENHAGEN, Denmark, [...]
Novartis Fabhalta® (iptacopan) meets Phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy (IgAN)
16/10/2025
In APPLAUSE-IgAN final analysis, Fabhalta demonstrated statistically significant, clinically meaningful improvement in estimated glomerular filtration rate (eGFR) slope vs. placebo over two years 1 eGFR is key marker of [...]
Kuros Biosciences increases the annual guidance for 2025, The company reports 77% year-over-year increase for the first nine months of 2025
16/10/2025
Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences increases the annual guidance for 2025 The company reports 77% year-over-year increase for the first nine months of 2025 Financial [...]
Roche presents major advances for its sequencing by expansion technology(1), including a new GUINNESS WORLD RECORD™, at the ASHG conference 2025
16/10/2025
Significant progress in bulk RNA sequencing, methylation mapping, multiomics integration, and spatial analyses unlocks research previously out of reach for traditional short read platforms. Leveraging Roche’s SBX [...]

Pages